Free Androgen Index (FAI) at Lahore PCR Lab

Book at Lahore PCR Lab · Lahore, Pakistan

Book this test

Lahore PCR  Lab logo

Lahore PCR Lab

40% off
Rs. 2,970Rs. 4,950

Compare other labs

Chughtai Lab logo

Chughtai Lab

20% off
Rs. 4,120Rs. 5,150
View lab
Dr. Essa Laboratories & Diagnostic Center logo

Dr. Essa Laboratories & Diagnostic Center

30% off
Rs. 4,361Rs. 6,230
View lab

Free Androgen Index (FAI) at Lahore PCR Lab

The Free Androgen Index (FAI) is a highly specialized diagnostic blood test used to evaluate the status of active male hormones, known as androgens, in the human body. Primarily utilized in clinical endocrinology and gynecology, this index provides a reliable estimation of physiologically active testosterone. While testosterone circulates in the bloodstream, the vast majority of it is bound to proteins—specifically Sex Hormone-Binding Globulin (SHBG) and albumin. Only a tiny fraction, typically 1% to 3%, remains unbound or “free.” This free portion, along with the weakly albumin-bound portion, represents the bioavailable testosterone that can readily enter cells and exert biological effects. The Free Androgen Index is a calculated ratio that compares the total concentration of testosterone to the concentration of SHBG, offering a highly accurate surrogate marker for free testosterone levels without the need for complex and expensive equilibrium dialysis methods.

At Lahore PCR Lab in Lahore, Pakistan, the Free Androgen Index is performed using state-of-the-art automated chemiluminescent immunoassay (CLIA) technology. By measuring both Total Testosterone and SHBG from a single blood sample, the laboratory’s advanced systems calculate the FAI using a standardized mathematical formula: FAI = (Total Testosterone in nmol/L / SHBG in nmol/L) x 100. This calculation is of paramount clinical importance because measuring total testosterone alone can often be highly misleading. For instance, a patient may have a normal total testosterone level, but if their SHBG levels are abnormally low, their biologically active free testosterone (and thus their FAI) will be significantly elevated, leading to symptoms of hyperandrogenism. Conversely, high SHBG levels can bind excessive amounts of testosterone, leaving insufficient free hormone available to the tissues. Therefore, the FAI serves as an invaluable diagnostic tool for identifying subtle hormonal imbalances that underlie various reproductive, metabolic, and dermatological conditions.

The diagnostic value of the Free Androgen Index is particularly pronounced in the evaluation of women presenting with signs of androgen excess, such as hirsutism (excessive male-pattern hair growth), severe or treatment-resistant acne, and female pattern alopecia (hair thinning). It is also a cornerstone investigation in the diagnostic workup for Polycystic Ovary Syndrome (PCOS), a common endocrine disorder affecting reproductive-aged women. In men, although direct measurement of free testosterone or calculated free testosterone using the Vermeulen equation is sometimes preferred, the FAI can still provide valuable insights into androgen status, especially when evaluating age-related decline in testosterone, hypogonadism, or disorders affecting SHBG production. By choosing Lahore PCR Lab, patients benefit from highly precise hormone assays, validated reference ranges, and expert interpretation by qualified consultant pathologists, ensuring an accurate foundation for clinical decision-making.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy and clinical reliability of your Free Androgen Index (FAI) test results at Lahore PCR Lab, patients must adhere to specific preparation guidelines. Because hormone levels fluctuate throughout the day and are influenced by various external factors, proper preparation is essential to avoid false elevations or depressions in the test values. Please follow these instructions carefully:

  • Diurnal Variation and Timing: Testosterone levels naturally peak in the early morning hours. Therefore, it is highly recommended that the blood sample be collected between 8:00 AM and 10:00 AM. This timing is critical for establishing a baseline that can be accurately compared against standardized reference ranges.
  • Fasting Requirements: While strict fasting is not always mandatory for a standalone FAI test, a fasting period of 8 to 12 hours (water is permitted) is highly recommended. Consuming a heavy meal, particularly one high in fats or carbohydrates, can temporarily suppress circulating testosterone levels, potentially skewing the results.
  • Medication and Supplement Review: Certain medications, including oral contraceptives, hormone replacement therapies, glucocorticoids, anticonvulsants, and anabolic steroids, can profoundly affect both testosterone and SHBG levels. Biotin (Vitamin B7) supplements, commonly taken for hair and nail health, can also interfere with the immunoassay technology used in the lab. Patients must discuss all current medications and supplements with their referring physician and the laboratory staff. It may be necessary to temporarily discontinue certain substances prior to testing, under medical supervision.
  • Stress and Physical Activity: Acute physical exertion, intense exercise, and severe emotional stress can alter hormone secretion. Patients should avoid strenuous workouts for 24 hours before the test and remain calm and rested prior to sample collection.
  • Menstrual Cycle Timing: For female patients, the timing of the test relative to the menstrual cycle is highly significant. Physicians typically recommend collecting the sample during the early follicular phase (usually days 2 to 5 of the menstrual cycle) to obtain a reliable baseline, unless otherwise specified by the specialist.

During the Procedure

The sample collection process for the Free Androgen Index at Lahore PCR Lab is a standard, safe, and routine venipuncture procedure. Upon arrival at the laboratory or during a home sample collection visit, the patient is greeted by a trained and experienced phlebotomist. The procedure involves the following steps:

  • Patient Identification and Verification: The phlebotomist will verify the patient’s identity using official identification and review the test requisition form to confirm the specific investigations ordered.
  • Positioning and Comfort: The patient is seated comfortably in a specialized blood collection chair. The phlebotomist will ask the patient to extend their arm, typically selecting the antecubital fossa (the crease of the elbow) as the primary site for venipuncture.
  • Site Preparation: The phlebotomist will apply a sterile tourniquet a few inches above the selected vein to increase blood flow and make the vein more visible and accessible. The skin at the puncture site is then thoroughly cleansed with an antiseptic alcohol swab and allowed to air dry to prevent contamination and minimize the risk of infection.
  • Venipuncture: A sterile, single-use, high-quality needle attached to a vacuum collection tube is gently inserted into the vein. Patients may feel a brief, mild pinch or stinging sensation as the needle enters the skin. Lahore PCR Lab utilizes advanced, low-pain needles to maximize patient comfort.
  • Sample Collection: Blood is drawn into a specific collection tube (typically a gold-top serum separator tube or a red-top clot activator tube) required for hormone assays. Once the necessary volume of blood is collected, the tourniquet is released, and the needle is carefully withdrawn.
  • Post-Puncture Care: Immediate pressure is applied to the puncture site with a sterile cotton ball or gauze pad to stop any bleeding. A small adhesive bandage is then applied. Patients are advised to keep the bandage on for at least a few hours and avoid lifting heavy objects with that arm for the remainder of the day.
  • Safety and Duration: The entire venipuncture process takes less than five minutes. All materials used are strictly sterile and disposable, eliminating any risk of cross-contamination. Patients can immediately resume their normal daily activities after the procedure.

When is a Free Androgen Index (FAI) Performed?

Evaluation of Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome (PCOS) is one of the most prevalent endocrine disorders among women of reproductive age, characterized by ovulatory dysfunction, polycystic ovarian morphology, and clinical or biochemical hyperandrogenism. Physicians frequently request the Free Androgen Index (FAI) at Lahore PCR Lab when a patient presents with symptoms suggestive of PCOS, such as irregular menstrual periods, chronic anovulation, infertility, and weight gain. Because total testosterone levels can remain within normal limits in a significant percentage of women with PCOS, the FAI is a far more sensitive marker. In PCOS, insulin resistance often leads to a compensatory hyperinsulinemia, which directly suppresses the hepatic production of Sex Hormone-Binding Globulin (SHBG). This reduction in SHBG results in a higher proportion of free, biologically active testosterone, which is accurately reflected as an elevated FAI. Identifying this biochemical hyperandrogenism assists clinicians in confirming a PCOS diagnosis according to the Rotterdam criteria and tailoring an appropriate management plan.

Investigation of Female Hirsutism and Virilization

Hirsutism, defined as the excessive growth of coarse, dark, terminal hair in women in androgen-dependent areas (such as the face, chest, abdomen, and back), is a distressing clinical symptom that warrants thorough hormonal evaluation. When a patient presents with hirsutism, often assessed clinically using the Ferriman-Gallwey scoring system, a physician will order an FAI test to determine if the hair growth is driven by elevated levels of circulating active androgens. In more severe cases, patients may exhibit signs of virilization, which include deepening of the voice, clitoromegaly, increased muscle mass, and temporal hair recession. Virilization is a clinical red flag that can indicate severe androgen excess, potentially arising from androgen-secreting tumors of the ovaries or adrenal glands, or late-onset Congenital Adrenal Hyperplasia (CAH). The FAI test helps differentiate between mild, functional androgen excess (such as in PCOS) and the extreme elevations associated with neoplastic or genetic disorders, guiding the clinician toward appropriate imaging studies or specialized endocrine testing.

Assessment of Unexplained Acne and Female Pattern Alopecia

Dermatological complaints are among the most common reasons patients seek medical attention for potential hormonal imbalances. Severe, cystic, or treatment-resistant acne in adult women, particularly when localized to the jawline and neck, is frequently driven by androgen stimulation of the sebaceous glands, leading to increased sebum production and clogged pores. Similarly, female pattern alopecia, characterized by diffuse thinning of hair at the crown of the head with preservation of the frontal hairline, is highly sensitive to androgen levels. When these dermatological symptoms do not respond to standard topical or systemic therapies, dermatologists and endocrinologists request a Free Androgen Index at Lahore PCR Lab. By evaluating the FAI, clinicians can determine if an underlying biochemical androgen excess is fueling the skin and hair follicles. If the FAI is elevated, systemic anti-androgen therapies, such as spironolactone or specific oral contraceptive pills, may be indicated to address the root hormonal cause rather than relying solely on topical treatments.

Monitoring of Hormone Replacement Therapy (HRT) and Gender-Affirming Care

The Free Androgen Index is an essential monitoring tool for patients undergoing various forms of hormonal therapy. In women receiving androgen therapy for hypoactive sexual desire disorder (HSDD) or postmenopausal hormone replacement therapy (HRT), monitoring the FAI ensures that testosterone levels remain within a safe, physiological female range, preventing the development of unwanted androgenic side effects. Conversely, in gender-affirming hormone therapy for transgender individuals, the FAI is used to monitor the efficacy of hormone suppression or supplementation. For transgender women (male-to-female), the goal is to suppress androgen levels to the normal female range, which is verified by a low FAI. For transgender men (female-to-male), the goal is to achieve androgen levels within the normal male range, monitored through regular FAI evaluations. Lahore PCR Lab provides precise and reliable measurements that allow endocrinologists to safely titrate hormone dosages and minimize long-term health risks.

Evaluation of Male Hypogonadism and Androgen Disorders

In male patients, the Free Androgen Index can be a valuable adjunctive test when evaluating symptoms of hypogonadism, which include decreased libido, erectile dysfunction, fatigue, loss of muscle mass, increased body fat, and mood disturbances. While direct measurement of free testosterone is often preferred in male endocrinology, the FAI provides useful clinical information, particularly when alterations in SHBG levels are suspected. Conditions such as obesity, type 2 diabetes, hypothyroidism, and nephrotic syndrome can significantly decrease SHBG levels in men, while aging, hyperthyroidism, liver cirrhosis, and certain medications can elevate SHBG. By measuring both total testosterone and SHBG to calculate the FAI, clinicians can better understand whether a patient’s symptoms are due to a true deficiency in hormone production by the testes (primary or secondary hypogonadism) or are secondary to alterations in carrier proteins, allowing for a more accurate diagnosis and targeted treatment.

What Does a Free Androgen Index (FAI) Detect?

The Free Androgen Index (FAI) is a highly sensitive diagnostic parameter that reflects the complex interplay between androgen production and carrier protein availability. An abnormal FAI result can indicate a wide spectrum of physiological changes, endocrine disorders, and systemic diseases. Specifically, a Free Androgen Index test can detect, evaluate, or assist in the diagnosis of:

  • Biochemical hyperandrogenism in female patients
  • Polycystic Ovary Syndrome (PCOS) and associated metabolic imbalances
  • Idiopathic hirsutism (excessive hair growth with normal ovulatory cycles)
  • Androgen-secreting ovarian tumors (e.g., Sertoli-Leydig cell tumors)
  • Androgen-secreting adrenal tumors (adenomas or carcinomas)
  • Late-onset or Non-Classic Congenital Adrenal Hyperplasia (NCCAH)
  • Severe insulin resistance and metabolic syndrome affecting hepatic SHBG synthesis
  • Obesity-induced suppression of Sex Hormone-Binding Globulin (SHBG)
  • Hyperprolactinemia (which can alter adrenal androgen secretion)
  • Cushing’s syndrome (excess cortisol production affecting androgen pathways)
  • Hypothyroidism (which characteristically decreases SHBG levels, raising FAI)
  • Hyperthyroidism (which characteristically increases SHBG levels, lowering FAI)
  • Hepatic dysfunction or liver cirrhosis (altering the synthesis of SHBG)
  • Estrogen deficiency or excess (estrogens stimulate hepatic SHBG production)
  • Androgen deficiency in males (male hypogonadism)
  • Age-related decline in male androgen levels (andropause)
  • Hormonal causes of female pattern baldness (androgenetic alopecia)
  • Endocrine-related severe, cystic acne vulgaris
  • Efficacy of ovarian suppression therapy (e.g., GnRH agonists)
  • Efficacy of anti-androgen medical therapies (e.g., spironolactone, flutamide)
  • Compliance and physiological response in gender-affirming hormone therapy
  • Hormonal imbalances contributing to female infertility and recurrent pregnancy loss
  • Anovulatory uterine bleeding secondary to androgen excess
  • SHBG fluctuations caused by oral contraceptive use or hormone replacement therapy
  • Anabolic steroid abuse or exogenous androgen administration

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that receiving timely and accurate diagnostic reports is crucial for patient peace of mind and prompt clinical intervention. The Free Androgen Index (FAI) is a specialized endocrine assay that requires precise laboratory processing, including the separate measurement of Total Testosterone and Sex Hormone-Binding Globulin (SHBG) followed by mathematical calculation. Typically, the turnaround time for the FAI test at Lahore PCR Lab is within 24 to 48 hours from the time of sample collection. This timeline ensures that the samples undergo rigorous quality control, calibration, and validation by our consultant pathologists before the final report is released.

Lahore PCR Lab offers convenient and modern methods for patients to access their diagnostic reports. Once the test results are validated and finalized, patients receive an automated SMS notification on their registered mobile number containing a direct, secure link to download their report in PDF format. Additionally, patients can access their reports at any time through the official Lahore PCR Lab online portal by entering their unique patient ID and password. For those who prefer physical copies, printed reports can be collected directly from the laboratory’s main reception or any of its designated collection centers across Lahore. This seamless digital integration ensures that both patients and their referring physicians can access critical diagnostic data promptly, facilitating timely medical consultations and treatment adjustments.

Free Androgen Index (FAI) Findings Overview

The following table provides a general clinical overview of the parameters evaluated during a Free Androgen Index (FAI) test, along with typical normal findings and potential abnormal findings. Please note that reference ranges can vary slightly depending on the specific laboratory equipment, reagents, and patient demographics.

Structure / Parameter Evaluated Normal Findings Possible Abnormal Findings
Total Testosterone (Female) 0.2 – 1.7 nmol/L (varies by age and menstrual phase) Elevated: PCOS, ovarian/adrenal tumors, CAH.
Decreased: Addison’s disease, primary ovarian insufficiency.
Total Testosterone (Male) 8.6 – 29.0 nmol/L (varies significantly by age) Elevated: Androgen resistance, exogenous steroid use.
Decreased: Hypogonadism, testicular failure, pituitary disorders.
Sex Hormone-Binding Globulin (SHBG) – Female 18 – 144 nmol/L (influenced by estrogen levels) Elevated: Pregnancy, hyperthyroidism, oral contraceptive use.
Decreased: Obesity, insulin resistance, PCOS, hypothyroidism.
Sex Hormone-Binding Globulin (SHBG) – Male 10 – 57 nmol/L (increases naturally with age) Elevated: Aging, hyperthyroidism, liver cirrhosis, estrogen therapy.
Decreased: Obesity, nephrotic syndrome, androgen use, hypothyroidism.
Calculated Free Androgen Index (FAI) – Female Typically < 5% to 6% (method and age-dependent) Elevated (> 6%): Biochemical hyperandrogenism, PCOS, hirsutism.
Decreased: Rare clinical significance unless evaluating adrenal insufficiency.
Calculated Free Androgen Index (FAI) – Male Typically 30% – 150% (highly age-dependent) Elevated: Exogenous testosterone abuse, androgen receptor insensitivity.
Decreased (< 30%): Male hypogonadism, androgen deficiency, severe obesity.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for Free Androgen Index (FAI)?

  • Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified consultant pathologists, clinical biochemists, and skilled technologists who specialize in complex endocrine assays.
  • Patient-Focused Care: We prioritize patient comfort, privacy, and dignity throughout the entire testing process, from sample collection to reporting.
  • Quality Diagnostic Services: Lahore PCR Lab adheres to strict internal and external quality control protocols, ensuring that every hormone assay meets international standards of accuracy.
  • Professional Reporting: Our reports are detailed, clear, and include comprehensive reference ranges tailored to age, gender, and clinical context, facilitating easy interpretation for physicians.
  • Modern Diagnostic Approach: We utilize state-of-the-art automated chemiluminescent immunoassay (CLIA) analyzers that minimize human error and deliver highly reproducible results.
  • Comfortable Environment: Our diagnostic centers in Lahore are designed to provide a clean, hygienic, and welcoming environment, reducing patient anxiety during clinical procedures.
  • Convenient Location: Located centrally in Lahore, Pakistan, our laboratory and collection centers are easily accessible, offering ample parking and flexible operating hours.
  • Commitment to Accurate Diagnosis: We are dedicated to providing precise, evidence-based diagnostic insights that empower clinicians to make informed, life-changing medical decisions for their patients.

Frequently Asked Questions